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TO THE EDITOR
Senescence is a state wherein cells are
metabolically active but are unable to
replicate due to the increased expres-
sion of cell cycle check point proteins,
such as p16INK4A, that prevent passage
of cells through the cycle. p16INK4A
expression increases significantly in the
basal layer of human epidermis and in
dermal fibroblasts, making it a reliable
in vivo biomarker of cellular aging in
human skin (Krishnamurthy et al., 2004;
Ressler et al., 2006; Waaijer et al.,
2012). Moreover, p16INK4A has contin-
ued to gain strong support as an
important component of the aging
process (Sharpless, 2004; Campisi and
d’Adda di Fagagna, 2007; Baker et al.,
2011).
Using in vitro living skin equivalent
(LSE) models constructed in-house (Aho
et al., 2012) with epidermal keratino-
cytes (HEKs) from photo-protected
sites of different age human donors,
and a single neonatal fibroblast donor
(Supplementary Information online), we
demonstrate that the age of the kerati-
nocyte donor differentially impacts the
model’s phenotype. Additionally, we
have notably demonstrated that it is
possible to develop an atrophic, aged
model made from young (30–40 years)
donor HEKs and to revert aged (53–66
years) donor HEK LSEs to a younger
phenotype, by modulating the level of
p16INK4A expression.
Similar to in vivo, we confirmed that
the level of p16INK4A in the aged
model increases in the basal cell layer
and in the lower epidermis, supporting
its usefulness as a biomarker for the
aging phenotype. HEKs from two young
donors formed normal stratified epider-
mis with a well-organized basal layer,
distinct cell layers, and a normal pattern
of differentiation (Figure 1a, left).
Models using five different aged donor
HEKs displayed an unorganized basal
cell layer, fewer spinous and granular
layers, and impaired differentiation,
as reflected by decreased filaggrin
immunostaining (Figure 1a, right). In
this model, substantially fewer Ki-67
positive–stained cells were seen in the
basal layer. This decrease is in agree-
ment with the observations of Gilhar
et al. (2004) in skin biopsies; however,
others have seen either an increase
(Giangreco et al., 2010) or no change
(Ressler et al., 2006) in Ki-67 staining
with age in vivo. This may be due to
variations between donors or due to
in vitro to in vivo differences.
We compared p16INK4A expression
in LSEs made from young and aged
donor cells by immunohistochemistry
(IHC) and immunoblot, and the micro-
graphs shown are representative of the
donor strains tested. In the young donor
LSEs, light staining of p16INK4A was
observed throughout the epidermis
and at a later time point, staining was
specifically localized to the basal layer.
In these samples, p16INK4A was barely
detectable by immunoblot (Figure 1b
and c). Conversely, we saw higher
p16INK4A expression in the aged LSEs
from an early time point and throughout
the experiment. Strong staining was
identified within the basal cell layer
and in the lower stratum spinosum by
IHC, substantiated by increased protein
detected by immunoblot. This increase
in p16INK4A appears to be inversely
correlated with the decrease seen in
markers of proliferation and differentia-
tion, as first observed by Ressler et al.
(2006).
Next, we altered the expression of
p16INK4A in LSEs produced from young
donor HEKs by lentiviral expression of
p16INK4A, driven by a truncatedAccepted article preview online 11 November 2013; published online 12 December 2013
Abbreviations: HEK, human epidermal keratinocyte; IHC, immunohistochemistry; K14, keratin 14;
LSE, living skin equivalent
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keratin 14 (K14) promoter (Di Nunzio
et al., 2008) to target delivery to the
physiologically relevant basal layer of
epidermis. Here, we observed a drama-
tic difference in phenotype between
LSEs overexpressing p16INK4A and the
controls (Figure 2a). Cultures with
increased p16INK4A expression showed
significant atrophy, with a thinner viable
epidermis and no apparent stratum cor-
neum, analogous to the LSEs we had
previously prepared from aged donor
HEKs. We confirmed these findings with
another young donor (not shown), and
in both models we observed a pheno-
typic dose-dependent response, where
the severity of atrophy was dependent
on the level of p16 gene expression in
the model (Figure 2b).
In the young donor LSEs overexpres-
sing p16INK4A, dose-dependent down-
regulation of Ki-67, filaggrin, and
caspase-14 was observed as compared
to the control samples. Moreover,
increased levels of p16INK4A protein
were detected by IHC in the p16INK4A-
infected LSEs, with strong staining in the
basal layer reflecting detection of both
endogenous and recombinant protein.
This was confirmed by the differential
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Figure 1. p16INK4A is associated with the aging epidermis. (a) Formalin-fixed, paraffin-embedded (FFPE)
sections from young and aged donor keratinocyte living skin equivalent (LSE) models harvested at 7 days
post air exposure. Sections were stained with hematoxylin and eosin or immunostained for detection of
filaggrin (FLG), Ki-67, and p16INK4A. (b) Expression of p16INK4A protein from monolayer cell lysates
(15mg) harvested at the time of application to the LSE. (c) Representative immunoblot analysis for
p16INK4A from young and aged LSE lysates (15mg) from duplicate cultures harvested at three different time
points post air exposure. Bar¼100mm, applies to all FFPE images.
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Figure 2. Reversal of phenotype by targeting p16INK4A in the LSE. (a) Young donor keratinocyte living skin equivalents (LSEs) infected with K14 promoter
driven either p16INK4A (left) or lacZ control (right) lentivirus, harvested at 11 days post air exposure. Formalin-fixed, paraffin-embedded (FFPE) sections were
stained with hematoxylin and eosin (H&E) or immunostained for V5, filaggrin (FLG), Ki-67, or p16INK4A. (b) Immunoblot analysis for caspase-14 (6mg, left)
and for p16INK4A (25mg, right, bottom). (c) Aged donor keratinocyte LSEs infected with either p16 miR (left) or non-silencing control miR (right) lentivirus,
harvested 7 days post air exposure. FFPE sections were stained with H&E or immunostained for filaggrin (FLG), Ki-67, or p16INK4A. (d) LSE lysates (15mg) were
analyzed for p16INK4A and for the differentiation markers loricrin and caspase-14. r-p16, recombinant p16INK4A; e-p16, endogenous p16. Bar¼ 100mm.
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banding pattern seen by immunoblot.
The lower amounts of Ki-67 staining
when p16INK4A expression is high
suggests that downregulation of prolif-
eration is occurring. This decrease is
likely a consequence of its increased
inhibitory effects on CDK4/6 and the
retinoblastoma pathway, resulting in
cell cycle arrest (Ortega et al., 2002)
and increased senescence (Alcorta
et al., 1996). Unexpectedly, we ob-
served that the level of endoge-
nous p16INK4A expression appeared
higher in the p16INK4A overexpression
model. We speculate that the presence
of recombinant p16INK4A protein
might indirectly upregulate endogenous
p16INK4A protein through various
detrimental factors excreted from an
increased number of senescent cells.
On the basis of these observations,
we decided to explore the biological
consequences of silencing p16INK4A in
the aged donor LSE model. Here, we
saw a dramatic improvement in the
morphology of the aged donor LSE,
which now resembled that of a much
younger donor (Figure 2c and d). A
striking difference between these LSEs
and the atrophic, non–silenced controls
was the substantial increase of Ki-67-
positive cells in the p16INK4A-silenced
cultures with a consequent normaliza-
tion of terminal differentiation, as
detected by the restoration of filaggrin,
loricrin, and caspase expression. This
was repeated in at least three other aged
donor models with similar results. In
accordance with the conditional knock-
out model of Baker et al. (2011), in
which senescent p16INK4A-expressing
cells were selectively eliminated, and as
evidenced by this model’s morphology
and biomarkers, our results indicate that
the atrophic phenotype can be signi-
ficantly improved in vitro by selectively
silencing the expression of p16INK4A.
Collectively, these results further sub-
stantiate p16INK4A as a major regulator
of aging in the epidermis, thus lending
strong support for furthering our knowl-
edge on the function and appearance of
aged skin.
For human cells obtained from donors,
the Declaration of Helsinki protocols
were followed; donors gave written,
informed consent; and the Stony Brook
University IRB approved of the study.
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TO THE EDITOR
We read with interest Chren et al.’s
study on the recurrence rates of
nonmelanoma skin cancer (NMSC)
treatments and the accompanying com-
mentary by Dr Stern entitled Cost Effec-
tiveness of Mohs Micrographic Surgery
(Chren et al., 2013, Stern, 2013). Dr
Chren described the recurrence rates for
NMSCs diagnosed and treated at the
San Francisco VA and UCSF dermato-
logy clinics. The biopsying dermatolo-
gists selected the skin cancer treatment
method (destruction, excision, or Mohs
surgery.) The authors concluded that
these treatments for NMSC were atAccepted article preview online 12 November 2013; published online 21 November 2013
Abbreviation: NMSC, nonmelanoma skin cancer
HW Rogers et al.
Properly Selected Skin Cancer Treatments
www.jidonline.org 1133
